SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RetiredNow who wrote (381333)4/29/2008 8:16:54 PM
From: Tenchusatsu  Read Replies (2) of 1574097
 
Mindmeld, > Well, for example, my company and most companies in America use their bargaining power to represent their employees to get better deals for them with the insurance companies.

Try again. Dealing with insurance companies is not the same as directly dealing with pharmaceutical companies.

Even when generics are available, insurance companies are under the gun by their customers to get them brand-name medication because, well, they saw the commercials. Plus there is a negative perception of generics that is arguably fostered by Big Pharma.

And that doesn't even cover the problem when generics aren't available because the drug maker has the patent. How much should Big Pharma charge in terms of profits for patent exclusivity?

Tenchusatsu
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News